INTERNATIONAL PATENT: BLUEROCK THERAPEUTICS LP FILES APPLICATION FOR "METHODS AND COMPOSITIONS FOR TREATING PROGRANULIN DEFICIENCIES USING IPSC-DERIVED CELLS"

GENEVA, Dec. 11 -- BLUEROCK THERAPEUTICS LP (238 Main Street, 3rd FloorCambridge, MA 02142) filed a patent application (PCT/US2025/031799) for "METHODS AND COMPOSITIONS FOR TREATING PROGRANULIN DEFICIENCIES USING iPSC-DERIVED CELLS" on May 30, 2025. With publication no. WO/2025/251041, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CALDAS, Diego Buenaventura (238 Main Street, 3rd FloorCambridge, MA 02142), PATSCH, Christoph (238 Main Street, 3rd FloorCambridge, MA 02142), DOUVARAS, Panagiotis (238 Main Street, 3rd FloorC...